Fibronectin splice variants containing the EIIIA and/or EIIIB exons are prominently expressed in the vasculature of a variety of human tumors but not in normal adult tissues. To understand the functions of these splice variants in physiological and tumor angiogenesis, we used EIIIB-null and EIIIA-null strains of mice to examine neovascularization of mouse retinas, pancreatic tumors in Rip-Tag transgenic mice, and transplanted melanomas. Contrary to expectations, physiological and tumor angiogenesis was not significantly affected by the absence of either EIIIA or EIIIB splice variants. Tumor growth was also not affected. In addition, the expression levels of smooth muscle alpha actin, believed to be modulated by EIIIA-containing fibronectins, were not affected either. Our experiments show that despite their tight regulation during angiogenesis, the presence of EIIIA or EIIIB splice variants individually is not essential for neovascularization.Angiogenesis is a process whereby new blood vessels develop from the preexisting vasculature (5). This process is crucial to provide oxygen and nutrients to a growing tumor mass; without a vascular supply, tumors fail to grow beyond 1.5 mm in diameter (15,25). Inhibition of tumor angiogenesis leads to inhibition or retardation of tumor growth in animal tumor models (7). The extracellular milieu plays a prominent role in tumor development by supplying factors that can either enhance (e.g., matrix metalloproteinases [12] or vascular endothelial growth factor [2, 28]) or inhibit (e.g., thrombospondin [48] or tumstatin [23]) tumor growth. Extracellular matrix proteins, including fibronectin (FN) and its splice variants, are prominently expressed in and around tumors (10,32,47), but their roles in tumorigenesis are poorly understood. This study investigated the potential functions of FN splice variants, EIIIA and EIIIB, in physiological and tumor angiogenesis.FN is a large modular glycoprotein composed of type I, type II, and type III FN repeats and implicated in numerous cellular processes from cell migration to hemostasis (27, 39). FN-null embryos and embryoid bodies have very low numbers of endothelial cells and develop defective vessels (16, 18), and FNnull embryos die very early in utero from cardiovascular defects (18-20). These observations underscore the importance of FN in vascular development.FN RNA is alternatively spliced at three conserved regions,
EIIIA (EDA), EIIIB (EDB), and V (CS-1). Although EIIIA and EIIIB sequences are only 29% identical within a species, interspecies comparisons show that amino acid sequences of EIIIB and EIIIA are highly conserved. For example, the mouse and human EIIIB and EIIIA segments are 100% and 96% identical, respectively. The patterns of expression of these splice variants are also conserved among species. In vivo, EIIIA and EIIIB FN splice variants are expressed around developing blood vessels during embryonic growth (14, 21, 44) when vessels are actively forming and being remodeled, but they are markedly downregulated in adult tiss...